- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05492422
Central Executive Training and Parent Training for ADHD
May 5, 2026 updated by: Michael J. Kofler, Florida State University
Evaluating the Efficacy of Sequenced Central Executive and Behavioral Parent Training for Children With ADHD
The goal of the current project is to combine two evidence- based treatments for school-aged children with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT).
CET is a computerized training intervention that improves ADHD symptoms and academic functioning by improving children's working memory abilities.
BPT is a therapeutic intervention that improves family functioning and child oppositional-defiant (ODD) symptoms by changing parenting behaviors.
Their combined use is expected to provide complementary and additive benefits, particularly if CET is delivered before BPT.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Children's Learning Clinic
- Phone Number: 8506457423
- Email: clc@psy.fsu.edu
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32306
- Recruiting
- Florida State University
-
Contact:
- Children's Learning Clinic
- Phone Number: 850-645-7423
- Email: clc@psy.fsu.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 13 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion:
- Children ages 8-12 with principal ADHD diagnoses (via K-SADS); and
- parent AND teacher ratings in clinical/borderline range based on age and sex on ADHD Rating Scale (ADHD-5) or Behavior Assessment Scale for Children (BASC-3) Attention Problems/Hyperactivity subscales (i.e., 90th percentile or higher based on both informants).
All DSM-5 ADHD presentations will be eligible.
Exclusion:
- gross neurological, sensory, or motor impairment;
- history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with participation (e.g., disruptive mood dysregulation, intermittent explosive, reactive attachment, substance use);
- intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form standard score <70;
- conditions requiring acute intervention, e.g., active suicidality; and
- non-English speaking child or parent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CET-then-BPT
Families receive CET in Phase 1 followed by BPT in Phase 2
|
Central Executive Training (CET)
Behavioral Parent Training (BPT)
|
|
Experimental: BPT-then-CET
Families receive BPT in Phase 1 followed by CET in Phase 2
|
Central Executive Training (CET)
Behavioral Parent Training (BPT)
|
|
Experimental: Waitlist then CET+BPT
Families do not receive either intervention in Phase 1 and then receive both CET and BPT concurrently in Phase 2
|
Central Executive Training (CET)
Behavioral Parent Training (BPT)
|
|
Experimental: CET+BPT then 'waitlist' (follow-up)
Families receive CET and BPT concurrently in Phase 1, and then are followed in Phase 2 with not additional intervention
|
Central Executive Training (CET)
Behavioral Parent Training (BPT)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Rapport visuospatial/phonological working memory test
Time Frame: Administered during a 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Administered during a 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
|
Alabama parenting scale
Time Frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
|
Parenting sense of competence scale
Time Frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
|
Parent stress index
Time Frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Behavior Assessment System for Children
Time Frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
|
ADHD Rating Scale
Time Frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
|
ODD symptoms (DSM-based checklist)
Time Frame: Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Parent and teacher questionnaire requiring approximately 15 minutes to complete, administered to parent and mailed to teacher while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Academic performance rating scale
Time Frame: Teacher questionnaire requiring approximately 15 minutes to complete, mailed to teacher within 2 weeks of last intervention session
|
Teacher questionnaire requiring approximately 15 minutes to complete, mailed to teacher within 2 weeks of last intervention session
|
|
Parent relationship questionnaire
Time Frame: Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
Parent questionnaire requiring approximately 15 minutes to complete, administered to parent while child is completing the 3 hour post-treatment testing session occurring within 2 weeks of last intervention session
|
|
Dyadic parent-child interaction coding system (DPICS)
Time Frame: Structured parent-child interaction conducted during the post-treatment testing session within 2 weeks of final intervention session
|
Structured parent-child interaction conducted during the post-treatment testing session within 2 weeks of final intervention session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 3, 2022
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Study Registration Dates
First Submitted
August 1, 2022
First Submitted That Met QC Criteria
August 4, 2022
First Posted (Actual)
August 8, 2022
Study Record Updates
Last Update Posted (Actual)
May 7, 2026
Last Update Submitted That Met QC Criteria
May 5, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01MH125893 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD
-
St. Antonius HospitalNot yet recruitingADHD | Attention Deficit Disorder with Hyperactivity | Attention Deficit Disorder | ADD | ADHD Predominantly Inattentive Type | ADHD, Predominantly Hyperactive - Impulsive | Attention Deficit Disorder (ADD) | Hyperactivity | Inattention | ADHD Predominantly Hyperactivity Type | ADHD-not Other Specified | Hyperactivity... and other conditions
-
Wuhan Sports UniversityTerminatedADHD | ADHD - Combined Type | ADHD - Inattentive Type | ADHD - Attention Deficit Disorder With Hyperactivity | ADHD Specifically With Executive Function ImpairmentChina
-
The Hong Kong Polytechnic UniversityRecruiting
-
Loewenstein HospitalWingate InstituteRecruiting
-
Region Örebro CountyActive, not recruiting
-
University of TorontoCompleted
-
Massachusetts General HospitalCenter for Survey Research, University of Massachusetts, BostonCompleted
-
Akili Interactive Labs, Inc.Active, not recruiting
-
L'hôpital Nord-Ouest - Villefranche Villefranche...Completed
-
Johns Hopkins UniversityWithdrawn
Clinical Trials on Central Executive Training (CET)
-
Florida State UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)Completed
-
Karolinska InstitutetSwedish Red Cross University CollegeCompleted
-
Research Foundation for Mental Hygiene, Inc.Columbia UniversityWithdrawn
-
University of Missouri, Kansas CityUniversity of KansasUnknownPosttraumatic Stress DisordersUnited States
-
Chen LiSouthwest University, ChinaRecruiting
-
Xinhua Hospital, Shanghai Jiao Tong University...Completed
-
Education University of Hong KongRecruiting
-
ZIli FanUnknown
-
Xinhua Hospital, Shanghai Jiao Tong University...Active, not recruitingADHD | Child, OnlyChina